A detailed history of Health Invest Partners Ab transactions in Arcellx, Inc. stock. As of the latest transaction made, Health Invest Partners Ab holds 22,496 shares of ACLX stock, worth $1.92 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
22,496
Previous 17,496 28.58%
Holding current value
$1.92 Million
Previous $1.22 Million 2.06%
% of portfolio
0.78%
Previous 0.75%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$49.74 - $66.98 $248,700 - $334,900
5,000 Added 28.58%
22,496 $1.24 Million
Q1 2024

Apr 25, 2024

BUY
$51.85 - $73.49 $316,077 - $447,995
6,096 Added 53.47%
17,496 $1.22 Million
Q4 2023

Jan 30, 2024

BUY
$31.75 - $57.99 $357,441 - $652,851
11,258 Added 7928.17%
11,400 $632,000
Q4 2022

Feb 14, 2023

BUY
$17.18 - $33.0 $2,439 - $4,686
142 New
142 $4,000

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $3.73B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Health Invest Partners Ab Portfolio

Follow Health Invest Partners Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

News

Stay updated on Health Invest Partners Ab with notifications on news.